Saudi Arabia Lysosomal Storage Disease Types Treatment Market Size & Outlook
Related Markets
Saudi Arabia lysosomal storage disease types treatment market highlights
- The Saudi Arabia lysosomal storage disease types treatment market generated a revenue of USD 22.2 million in 2024 and is expected to reach USD 38.3 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 6.3% from 2025 to 2033.
- In terms of segment, enzyme replacement therapy (ert) was the largest revenue generating type in 2024.
- Other Type is the most lucrative type segment registering the fastest growth during the forecast period.
Lysosomal storage disease types treatment market data book summary
| Market revenue in 2024 | USD 22.2 million |
| Market revenue in 2033 | USD 38.3 million |
| Growth rate | 6.3% (CAGR from 2025 to 2033) |
| Largest segment | Enzyme replacement therapy (ert) |
| Fastest growing segment | Other Type |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Other Type |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.5% of the global lysosomal storage disease types treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa lysosomal storage disease types treatment market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 13.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lysosomal Storage Disease Types Treatment Market Scope
Lysosomal Storage Disease Types Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amicus Therapeutics Inc | View profile | 517 | 47 Hulfish Street, Princeton, NJ, United States, 08542 | https://www.amicusrx.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
Saudi Arabia lysosomal storage disease types treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lysosomal storage disease types treatment market will help companies and investors design strategic landscapes.
Enzyme replacement therapy (ert) was the largest segment with a revenue share of 87.39% in 2024. Horizon Databook has segmented the Saudi Arabia lysosomal storage disease types treatment market based on enzyme replacement therapy (ert), substrate reduction therapy (srt), other type covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Saudi Arabia lysosomal storage disease types treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia lysosomal storage disease types treatment market databook
-
Our clientele includes a mix of lysosomal storage disease types treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia lysosomal storage disease types treatment market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia lysosomal storage disease types treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia lysosomal storage disease types treatment market size, by type, 2021-2033 (US$M)
Saudi Arabia Lysosomal Storage Disease Types Treatment Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
